U.S. stock futures edged higher on Monday as investors monitored corporate dealmaking activity and developments in the biotechnology and cryptocurrency sectors.

Biotech stocks were in focus in premarket trading after a major acquisition announcement, while Bitcoin-linked names also advanced.

At 08:34 ET (12:34 GMT), S&P 500 futures added 0.1%, Nasdaq 100 futures climbed 0.4%, while Dow futures advanced 0.3%.

Here are some of the biggest premarket U.S. stock movers today:

• Apogee Therapeutics shares surged 47% after AbbVie agreed to acquire the biotechnology company for $10.9 billion. The deal marks AbbVie’s largest acquisition in more than five years and is aimed at bolstering the drugmaker’s next-generation immunology pipeline.


• AbbVie rose 1.5% after announcing the takeover of Apogee Therapeutics, expanding its portfolio of immunology treatments as it seeks new growth drivers.


• BitFuFu gained 8.2% after the Bitcoin miner unveiled a share repurchase program authorizing the buyback of up to $5 million of its Class A ordinary shares over a two-year period.


• Nuvectis Pharma climbed 5.7% after entering a licensing agreement with Haisco Pharmaceutical Group for exclusive ex-China rights to two clinical-stage drug candidates. The deal adds a Complement Factor B inhibitor and a BRAF inhibitor to the company’s pipeline.


• Palvella Therapeutics rose 5% after the U.S. Food and Drug Administration granted rolling review for its New Drug Application for QTORIN rapamycin, a treatment under development for microcystic lymphatic malformations.


• Chevron gained 1.3% after the energy major announced a 20-year power purchase agreement with Microsoft to supply natural gas-fired electricity to a proposed data center campus in West Texas. The project is expected to deliver approximately 2.67 gigawatts of capacity and begin supplying power in 2028.